Veredus Laboratories’ VereCoV™ Detection Kit receives Singapore HSA Provisional Authorisation for IVD use
Jan 05, 2022
Original Published Date: 27 Feburary 2020
Veredus Laboratories Pte Ltd “Veredus” has obtained the Provisional Authorisation from Singapore Health Sciences Authority (HSA) for its VereCoV™ Detection Kit following Veredus’ rapid launch of this kit as a “Research Use Only” (RUO) test earlier this year. With this Authorisation, VereCoV™ Detection Kit can be used directly by laboratories or hospitals to test patients for clinical diagnosis.